Skip to main content
CV outcomes better with SGLT2 inhibitor than DPP4 inhibitor in T2DM study
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
CV outcomes better with SGLT2 inhibitor than DPP4 inhibitor in T2DM study
User login
Username
Password
Reset your password
Type
Lead
score